Literature DB >> 21689081

On estimation in relative survival.

Maja Pohar Perme1, Janez Stare, Jacques Estève.   

Abstract

Estimation of relative survival has become the first and the most basic step when reporting cancer survival statistics. Standard estimators are in routine use by all cancer registries. However, it has been recently noted that these estimators do not provide information on cancer mortality that is independent of the national general population mortality. Thus they are not suitable for comparison between countries. Furthermore, the commonly used interpretation of the relative survival curve is vague and misleading. The present article attempts to remedy these basic problems. The population quantities of the traditional estimators are carefully described and their interpretation discussed. We then propose a new estimator of net survival probability that enables the desired comparability between countries. The new estimator requires no modeling and is accompanied with a straightforward variance estimate. The methods are described on real as well as simulated data.
© 2011, The International Biometric Society.

Entities:  

Mesh:

Year:  2011        PMID: 21689081     DOI: 10.1111/j.1541-0420.2011.01640.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  143 in total

1.  Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study.

Authors:  Hla-Hla Thein; Edwin Khoo; Michael A Campitelli; Ahmad Zaheen; Qilong Yi; Prithwish De; C C Earle
Journal:  CMAJ Open       Date:  2015-04-02

2.  Nationwide implementation of laparoscopic surgery for colon cancer: short-term outcomes and long-term survival in a population-based cohort.

Authors:  Kjartan Stormark; Kjetil Søreide; Jon Arne Søreide; Jan Terje Kvaløy; Frank Pfeffer; Morten T Eriksen; Bjørn S Nedrebø; Hartwig Kørner
Journal:  Surg Endosc       Date:  2016-02-23       Impact factor: 4.584

3.  Secular trends in colon and rectal cancer relative survival.

Authors:  Carolyn M Rutter; Eric A Johnson; Eric J Feuer; Amy B Knudsen; Karen M Kuntz; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2013-10-30       Impact factor: 13.506

4.  A competing risks approach to "biologic" interaction.

Authors:  Per Kragh Andersen; Anders Skrondal
Journal:  Lifetime Data Anal       Date:  2015-01-23       Impact factor: 1.588

5.  Epidemiology: Cancer survival: global variation and long-term trends.

Authors:  Georgios Lyratzopoulos
Journal:  Nat Rev Clin Oncol       Date:  2015-03-03       Impact factor: 66.675

6.  Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  C Brooke Steele; Jun Li; Bin Huang; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

7.  Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Vicki B Benard; Meg Watson; Mona Saraiya; Rhea Harewood; Julie S Townsend; Antoinette M Stroup; Hannah K Weir; Claudia Allemani
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

8.  Population-based cancer survival in the United States: Data, quality control, and statistical methods.

Authors:  Claudia Allemani; Rhea Harewood; Christopher J Johnson; Helena Carreira; Devon Spika; Audrey Bonaventure; Kevin Ward; Hannah K Weir; Michel P Coleman
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

9.  Liver cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Behnoosh R Momin; Paulo S Pinheiro; Helena Carreira; Chunyu Li; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

10.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.